nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—CSF1R—blood plasma—Creutzfeldt-Jakob disease	0.0262	0.0281	CbGeAlD
Imatinib—ABCA3—spinal cord—Creutzfeldt-Jakob disease	0.0251	0.027	CbGeAlD
Imatinib—KIT—blood plasma—Creutzfeldt-Jakob disease	0.0238	0.0256	CbGeAlD
Imatinib—DDR1—spinal cord—Creutzfeldt-Jakob disease	0.0232	0.025	CbGeAlD
Imatinib—CA1—blood plasma—Creutzfeldt-Jakob disease	0.0217	0.0234	CbGeAlD
Imatinib—ABCA3—central nervous system—Creutzfeldt-Jakob disease	0.0204	0.0219	CbGeAlD
Imatinib—ABCA3—cerebellum—Creutzfeldt-Jakob disease	0.0199	0.0214	CbGeAlD
Imatinib—DDR1—cerebellum—Creutzfeldt-Jakob disease	0.0184	0.0198	CbGeAlD
Imatinib—NQO2—brainstem—Creutzfeldt-Jakob disease	0.0169	0.0182	CbGeAlD
Imatinib—HIPK4—brain—Creutzfeldt-Jakob disease	0.0164	0.0176	CbGeAlD
Imatinib—ABCA3—brain—Creutzfeldt-Jakob disease	0.0162	0.0174	CbGeAlD
Imatinib—CYP2C19—blood plasma—Creutzfeldt-Jakob disease	0.0154	0.0165	CbGeAlD
Imatinib—DDR1—brain—Creutzfeldt-Jakob disease	0.0149	0.0161	CbGeAlD
Imatinib—PIP4K2C—spinal cord—Creutzfeldt-Jakob disease	0.0143	0.0154	CbGeAlD
Imatinib—CA2—blood plasma—Creutzfeldt-Jakob disease	0.0141	0.0152	CbGeAlD
Imatinib—SLC47A1—brainstem—Creutzfeldt-Jakob disease	0.0136	0.0146	CbGeAlD
Imatinib—KIT—brainstem—Creutzfeldt-Jakob disease	0.0135	0.0145	CbGeAlD
Imatinib—CYP1A2—blood plasma—Creutzfeldt-Jakob disease	0.0126	0.0135	CbGeAlD
Imatinib—CA14—spinal cord—Creutzfeldt-Jakob disease	0.0124	0.0134	CbGeAlD
Imatinib—CYP3A5—blood plasma—Creutzfeldt-Jakob disease	0.0121	0.013	CbGeAlD
Imatinib—ABL2—cerebellum—Creutzfeldt-Jakob disease	0.012	0.0129	CbGeAlD
Imatinib—CYP2C9—blood plasma—Creutzfeldt-Jakob disease	0.0119	0.0128	CbGeAlD
Imatinib—CA7—cerebellum—Creutzfeldt-Jakob disease	0.0118	0.0127	CbGeAlD
Imatinib—ABL1—brainstem—Creutzfeldt-Jakob disease	0.0117	0.0126	CbGeAlD
Imatinib—PIP4K2C—central nervous system—Creutzfeldt-Jakob disease	0.0116	0.0125	CbGeAlD
Imatinib—PDGFRA—lymphoid tissue—Creutzfeldt-Jakob disease	0.0116	0.0124	CbGeAlD
Imatinib—PIP4K2C—cerebellum—Creutzfeldt-Jakob disease	0.0114	0.0122	CbGeAlD
Imatinib—CA3—central nervous system—Creutzfeldt-Jakob disease	0.0111	0.0119	CbGeAlD
Imatinib—PTGS1—blood plasma—Creutzfeldt-Jakob disease	0.0109	0.0117	CbGeAlD
Imatinib—ABCA3—Validated nuclear estrogen receptor alpha network—CTSD—Creutzfeldt-Jakob disease	0.0106	0.15	CbGpPWpGaD
Imatinib—NQO2—spinal cord—Creutzfeldt-Jakob disease	0.0105	0.0113	CbGeAlD
Imatinib—PDGFRA—spinal cord—Creutzfeldt-Jakob disease	0.0105	0.0113	CbGeAlD
Imatinib—CA9—cerebellum—Creutzfeldt-Jakob disease	0.0104	0.0112	CbGeAlD
Imatinib—CSF1R—lymphoid tissue—Creutzfeldt-Jakob disease	0.0102	0.011	CbGeAlD
Imatinib—CA14—cerebellum—Creutzfeldt-Jakob disease	0.00984	0.0106	CbGeAlD
Imatinib—ABL2—brain—Creutzfeldt-Jakob disease	0.00974	0.0105	CbGeAlD
Imatinib—CA7—brain—Creutzfeldt-Jakob disease	0.0096	0.0103	CbGeAlD
Imatinib—KIT—lymphoid tissue—Creutzfeldt-Jakob disease	0.00925	0.00995	CbGeAlD
Imatinib—CSF1R—spinal cord—Creutzfeldt-Jakob disease	0.00923	0.00994	CbGeAlD
Imatinib—PIP4K2C—brain—Creutzfeldt-Jakob disease	0.00922	0.00992	CbGeAlD
Imatinib—CYP3A4—blood plasma—Creutzfeldt-Jakob disease	0.00908	0.00978	CbGeAlD
Imatinib—PDGFRB—lymphoid tissue—Creutzfeldt-Jakob disease	0.00903	0.00972	CbGeAlD
Imatinib—CYP2D6—blood plasma—Creutzfeldt-Jakob disease	0.00894	0.00962	CbGeAlD
Imatinib—CA3—brain—Creutzfeldt-Jakob disease	0.0088	0.00947	CbGeAlD
Imatinib—NQO2—central nervous system—Creutzfeldt-Jakob disease	0.00853	0.00918	CbGeAlD
Imatinib—PDGFRA—central nervous system—Creutzfeldt-Jakob disease	0.00851	0.00915	CbGeAlD
Imatinib—CA1—lymphoid tissue—Creutzfeldt-Jakob disease	0.00846	0.0091	CbGeAlD
Imatinib—SLC47A1—spinal cord—Creutzfeldt-Jakob disease	0.00843	0.00907	CbGeAlD
Imatinib—KIT—spinal cord—Creutzfeldt-Jakob disease	0.00838	0.00902	CbGeAlD
Imatinib—NQO2—cerebellum—Creutzfeldt-Jakob disease	0.00834	0.00897	CbGeAlD
Imatinib—PDGFRA—cerebellum—Creutzfeldt-Jakob disease	0.00832	0.00895	CbGeAlD
Imatinib—PDGFRB—spinal cord—Creutzfeldt-Jakob disease	0.00819	0.00881	CbGeAlD
Imatinib—ABL1—lymphoid tissue—Creutzfeldt-Jakob disease	0.00805	0.00866	CbGeAlD
Imatinib—CA14—brain—Creutzfeldt-Jakob disease	0.00799	0.0086	CbGeAlD
Imatinib—CA2—brainstem—Creutzfeldt-Jakob disease	0.00799	0.0086	CbGeAlD
Imatinib—CA12—central nervous system—Creutzfeldt-Jakob disease	0.00785	0.00845	CbGeAlD
Imatinib—ORM1—spinal cord—Creutzfeldt-Jakob disease	0.00768	0.00827	CbGeAlD
Imatinib—CA1—spinal cord—Creutzfeldt-Jakob disease	0.00767	0.00825	CbGeAlD
Imatinib—CSF1R—central nervous system—Creutzfeldt-Jakob disease	0.00749	0.00806	CbGeAlD
Imatinib—CSF1R—cerebellum—Creutzfeldt-Jakob disease	0.00732	0.00788	CbGeAlD
Imatinib—ABL1—spinal cord—Creutzfeldt-Jakob disease	0.0073	0.00785	CbGeAlD
Imatinib—SLC47A1—central nervous system—Creutzfeldt-Jakob disease	0.00684	0.00736	CbGeAlD
Imatinib—KIT—central nervous system—Creutzfeldt-Jakob disease	0.0068	0.00732	CbGeAlD
Imatinib—NQO2—brain—Creutzfeldt-Jakob disease	0.00677	0.00729	CbGeAlD
Imatinib—PDGFRA—brain—Creutzfeldt-Jakob disease	0.00675	0.00727	CbGeAlD
Imatinib—SLC47A1—cerebellum—Creutzfeldt-Jakob disease	0.00669	0.00719	CbGeAlD
Imatinib—KIT—cerebellum—Creutzfeldt-Jakob disease	0.00665	0.00715	CbGeAlD
Imatinib—PDGFRB—central nervous system—Creutzfeldt-Jakob disease	0.00664	0.00715	CbGeAlD
Imatinib—PDGFRB—cerebellum—Creutzfeldt-Jakob disease	0.00649	0.00699	CbGeAlD
Imatinib—ABCB1—blood plasma—Creutzfeldt-Jakob disease	0.00643	0.00692	CbGeAlD
Imatinib—CA12—brain—Creutzfeldt-Jakob disease	0.00623	0.00671	CbGeAlD
Imatinib—ORM1—central nervous system—Creutzfeldt-Jakob disease	0.00623	0.00671	CbGeAlD
Imatinib—CA1—central nervous system—Creutzfeldt-Jakob disease	0.00622	0.00669	CbGeAlD
Imatinib—CSF1R—brain—Creutzfeldt-Jakob disease	0.00595	0.0064	CbGeAlD
Imatinib—ABL1—central nervous system—Creutzfeldt-Jakob disease	0.00592	0.00637	CbGeAlD
Imatinib—ABL1—cerebellum—Creutzfeldt-Jakob disease	0.00579	0.00623	CbGeAlD
Imatinib—SLC22A1—central nervous system—Creutzfeldt-Jakob disease	0.00571	0.00614	CbGeAlD
Imatinib—CA2—lymphoid tissue—Creutzfeldt-Jakob disease	0.00548	0.0059	CbGeAlD
Imatinib—SLC47A1—brain—Creutzfeldt-Jakob disease	0.00543	0.00584	CbGeAlD
Imatinib—KIT—brain—Creutzfeldt-Jakob disease	0.0054	0.00581	CbGeAlD
Imatinib—PDGFRB—brain—Creutzfeldt-Jakob disease	0.00527	0.00568	CbGeAlD
Imatinib—CYP2D6—brainstem—Creutzfeldt-Jakob disease	0.00507	0.00546	CbGeAlD
Imatinib—CA2—spinal cord—Creutzfeldt-Jakob disease	0.00497	0.00535	CbGeAlD
Imatinib—CA1—brain—Creutzfeldt-Jakob disease	0.00494	0.00531	CbGeAlD
Imatinib—ABL1—brain—Creutzfeldt-Jakob disease	0.0047	0.00506	CbGeAlD
Imatinib—ABCG2—spinal cord—Creutzfeldt-Jakob disease	0.0046	0.00495	CbGeAlD
Imatinib—SLC22A1—brain—Creutzfeldt-Jakob disease	0.00453	0.00488	CbGeAlD
Imatinib—DDR1—Extracellular matrix organization—CTSD—Creutzfeldt-Jakob disease	0.00449	0.0635	CbGpPWpGaD
Imatinib—ALB—brain—Creutzfeldt-Jakob disease	0.00434	0.00467	CbGeAlD
Imatinib—CA2—central nervous system—Creutzfeldt-Jakob disease	0.00403	0.00434	CbGeAlD
Imatinib—CA2—cerebellum—Creutzfeldt-Jakob disease	0.00394	0.00424	CbGeAlD
Imatinib—PTGS1—spinal cord—Creutzfeldt-Jakob disease	0.00384	0.00413	CbGeAlD
Imatinib—ABCG2—cerebellum—Creutzfeldt-Jakob disease	0.00365	0.00393	CbGeAlD
Imatinib—LCK—Glypican 1 network—PRNP—Creutzfeldt-Jakob disease	0.00334	0.0472	CbGpPWpGaD
Imatinib—CA2—brain—Creutzfeldt-Jakob disease	0.0032	0.00344	CbGeAlD
Imatinib—PTGS1—central nervous system—Creutzfeldt-Jakob disease	0.00311	0.00335	CbGeAlD
Imatinib—ABCG2—brain—Creutzfeldt-Jakob disease	0.00296	0.00319	CbGeAlD
Imatinib—NTRK1—Trk receptor signaling mediated by PI3K and PLC-gamma—YWHAZ—Creutzfeldt-Jakob disease	0.00267	0.0378	CbGpPWpGaD
Imatinib—LCK—Translocation of ZAP-70 to Immunological synapse—HLA-DQB1—Creutzfeldt-Jakob disease	0.00263	0.0372	CbGpPWpGaD
Imatinib—CYP3A4—central nervous system—Creutzfeldt-Jakob disease	0.0026	0.0028	CbGeAlD
Imatinib—CYP2D6—central nervous system—Creutzfeldt-Jakob disease	0.00256	0.00275	CbGeAlD
Imatinib—ABCB1—lymphoid tissue—Creutzfeldt-Jakob disease	0.0025	0.00269	CbGeAlD
Imatinib—CYP2D6—cerebellum—Creutzfeldt-Jakob disease	0.0025	0.00269	CbGeAlD
Imatinib—PTGS1—brain—Creutzfeldt-Jakob disease	0.00247	0.00266	CbGeAlD
Imatinib—LCK—Phosphorylation of CD3 and TCR zeta chains—HLA-DQB1—Creutzfeldt-Jakob disease	0.00242	0.0342	CbGpPWpGaD
Imatinib—ABCB1—spinal cord—Creutzfeldt-Jakob disease	0.00227	0.00244	CbGeAlD
Imatinib—LCK—PD-1 signaling—HLA-DQB1—Creutzfeldt-Jakob disease	0.00216	0.0306	CbGpPWpGaD
Imatinib—CYP2D6—brain—Creutzfeldt-Jakob disease	0.00203	0.00219	CbGeAlD
Imatinib—ABCB1—central nervous system—Creutzfeldt-Jakob disease	0.00184	0.00198	CbGeAlD
Imatinib—ABCB1—cerebellum—Creutzfeldt-Jakob disease	0.0018	0.00194	CbGeAlD
Imatinib—NTRK1—Circadian rythm related genes—NPAS2—Creutzfeldt-Jakob disease	0.00177	0.0251	CbGpPWpGaD
Imatinib—CA3—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.0017	0.0241	CbGpPWpGaD
Imatinib—LCK—Generation of second messenger molecules—HLA-DQB1—Creutzfeldt-Jakob disease	0.00166	0.0235	CbGpPWpGaD
Imatinib—ABL2—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00153	0.0216	CbGpPWpGaD
Imatinib—ABCB1—brain—Creutzfeldt-Jakob disease	0.00146	0.00157	CbGeAlD
Imatinib—LCK—Downstream TCR signaling—HLA-DQB1—Creutzfeldt-Jakob disease	0.00136	0.0193	CbGpPWpGaD
Imatinib—ABL1—Pathogenic Escherichia coli infection—YWHAZ—Creutzfeldt-Jakob disease	0.00116	0.0164	CbGpPWpGaD
Imatinib—PDGFRA—Allograft Rejection—HLA-DQB1—Creutzfeldt-Jakob disease	0.00111	0.0158	CbGpPWpGaD
Imatinib—CA14—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.0011	0.0155	CbGpPWpGaD
Imatinib—ABL2—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00109	0.0154	CbGpPWpGaD
Imatinib—CA6—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00107	0.0151	CbGpPWpGaD
Imatinib—LCK—TCR signaling—HLA-DQB1—Creutzfeldt-Jakob disease	0.00102	0.0144	CbGpPWpGaD
Imatinib—CA7—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.001	0.0141	CbGpPWpGaD
Imatinib—CA3—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000943	0.0133	CbGpPWpGaD
Imatinib—CA12—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000926	0.0131	CbGpPWpGaD
Imatinib—LCK—Costimulation by the CD28 family—HLA-DQB1—Creutzfeldt-Jakob disease	0.000908	0.0128	CbGpPWpGaD
Imatinib—CA2—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000708	0.01	CbGpPWpGaD
Imatinib—ABL1—Cell Cycle—YWHAZ—Creutzfeldt-Jakob disease	0.000708	0.01	CbGpPWpGaD
Imatinib—CA1—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000679	0.0096	CbGpPWpGaD
Imatinib—PTGS1—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.000651	0.0092	CbGpPWpGaD
Imatinib—PDGFRB—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.000617	0.00873	CbGpPWpGaD
Imatinib—CA14—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000607	0.00859	CbGpPWpGaD
Imatinib—ABL1—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.000602	0.00851	CbGpPWpGaD
Imatinib—CA9—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000597	0.00844	CbGpPWpGaD
Imatinib—CA6—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000592	0.00837	CbGpPWpGaD
Imatinib—LCK—Signaling by Interleukins—YWHAZ—Creutzfeldt-Jakob disease	0.000557	0.00788	CbGpPWpGaD
Imatinib—CA7—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000553	0.00782	CbGpPWpGaD
Imatinib—ABL1—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.000539	0.00763	CbGpPWpGaD
Imatinib—CA12—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000512	0.00724	CbGpPWpGaD
Imatinib—LCK—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.000495	0.00701	CbGpPWpGaD
Imatinib—ABCB1—Allograft Rejection—HLA-DQB1—Creutzfeldt-Jakob disease	0.000422	0.00597	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.000418	0.00591	CbGpPWpGaD
Imatinib—CA2—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000391	0.00554	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000385	0.00544	CbGpPWpGaD
Imatinib—CA1—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000375	0.00531	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.000375	0.00531	CbGpPWpGaD
Imatinib—PTGS1—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.00036	0.00509	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.000342	0.00484	CbGpPWpGaD
Imatinib—CA9—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.00033	0.00467	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000323	0.00457	CbGpPWpGaD
Imatinib—LCK—Platelet activation, signaling and aggregation—YWHAZ—Creutzfeldt-Jakob disease	0.000314	0.00444	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000306	0.00433	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000302	0.00427	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000299	0.00423	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000298	0.00422	CbGpPWpGaD
Imatinib—LCK—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.000293	0.00414	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.000292	0.00413	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00029	0.0041	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000278	0.00394	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000276	0.0039	CbGpPWpGaD
Imatinib—LCK—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.00026	0.00368	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.000231	0.00327	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.00023	0.00326	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000221	0.00313	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000218	0.00308	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000216	0.00306	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.000207	0.00293	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000204	0.00289	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000197	0.00278	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000196	0.00278	CbGpPWpGaD
Imatinib—KIT—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000196	0.00277	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000194	0.00274	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.000189	0.00268	CbGpPWpGaD
Imatinib—ALB—Platelet activation, signaling and aggregation—YWHAZ—Creutzfeldt-Jakob disease	0.000188	0.00266	CbGpPWpGaD
Imatinib—ALB—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000186	0.00263	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000186	0.00263	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000174	0.00247	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000167	0.00237	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000167	0.00236	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000167	0.00236	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000165	0.00234	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000165	0.00233	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000163	0.00231	CbGpPWpGaD
Imatinib—ABL1—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000163	0.0023	CbGpPWpGaD
Imatinib—LCK—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000162	0.00229	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.000162	0.00229	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.00016	0.00227	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000158	0.00223	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000154	0.00218	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000154	0.00217	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000152	0.00215	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.00014	0.00198	CbGpPWpGaD
Imatinib—KIT—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.00014	0.00198	CbGpPWpGaD
Imatinib—LCK—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000134	0.0019	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000132	0.00187	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00013	0.00184	CbGpPWpGaD
Imatinib—KIT—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000124	0.00175	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000119	0.00169	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000119	0.00169	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000117	0.00166	CbGpPWpGaD
Imatinib—ABL1—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000116	0.00164	CbGpPWpGaD
Imatinib—KIT—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000115	0.00162	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000109	0.00155	CbGpPWpGaD
Imatinib—PDGFRA—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000108	0.00153	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000106	0.0015	CbGpPWpGaD
Imatinib—ABL1—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000103	0.00146	CbGpPWpGaD
Imatinib—ALB—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000103	0.00146	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.0001	0.00142	CbGpPWpGaD
Imatinib—PDGFRB—Disease—YWHAZ—Creutzfeldt-Jakob disease	9.77e-05	0.00138	CbGpPWpGaD
Imatinib—ALB—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	9.68e-05	0.00137	CbGpPWpGaD
Imatinib—LCK—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	9.56e-05	0.00135	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—NPAS2—Creutzfeldt-Jakob disease	9.24e-05	0.00131	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—NPAS2—Creutzfeldt-Jakob disease	9.01e-05	0.00128	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—NPAS2—Creutzfeldt-Jakob disease	8.49e-05	0.0012	CbGpPWpGaD
Imatinib—LCK—Immune System—YWHAZ—Creutzfeldt-Jakob disease	8.49e-05	0.0012	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—NPAS2—Creutzfeldt-Jakob disease	8.42e-05	0.00119	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	8.02e-05	0.00113	CbGpPWpGaD
Imatinib—LCK—Disease—YWHAZ—Creutzfeldt-Jakob disease	7.84e-05	0.00111	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	7.59e-05	0.00107	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—NPAS2—Creutzfeldt-Jakob disease	7.2e-05	0.00102	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	6.84e-05	0.000967	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—NPAS2—Creutzfeldt-Jakob disease	5.55e-05	0.000786	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	5.49e-05	0.000776	CbGpPWpGaD
